Management of Stage IVB Cervical Cancer
Disease Classification and Treatment Intent
- The combination of paraaortic lymph node involvement and multiple pulmonary metastases confirms disseminated disease that is not amenable to curative treatment with surgery or radiation, according to the National Comprehensive Cancer Network 1
Role of Radiation Therapy in This Setting
- Individualized external beam radiation therapy may be considered for symptomatic sites, such as bulky paraaortic nodes causing pain or obstruction, but only as an adjunct to systemic therapy, not as definitive treatment, as recommended by the National Comprehensive Cancer Network 1
- Do not attempt curative-intent extended-field chemoradiation for patients with paraaortic lymph node involvement and distant metastases, as this approach is reserved for patients with paraaortic lymph node involvement without distant metastases, according to the National Comprehensive Cancer Network 1
Critical Pitfalls to Avoid
- Do not delay systemic chemotherapy to pursue surgical staging or debulking in patients with radiologically confirmed pulmonary metastases, as the presence of these metastases already establishes stage IVB disease, as stated by the National Comprehensive Cancer Network 1
Treatment of Cervical Cancer with Lymph Node and Lung Metastases
Disease Classification and Treatment Intent
- Cervical cancer with lung metastases represents FIGO stage IVB disease, which is treated with palliative intent rather than curative intent 2, 3, 4, 5, 6
Standard Chemotherapy Regimen
- Platinum-based combination chemotherapy has demonstrated potential benefit in FIGO stage IVB disease 2, 3, 4, 5, 6
Role of Radiation Therapy
- For disseminated disease with both lymph node and lung involvement, systemic chemotherapy is the primary treatment modality 2, 3, 4, 5, 6
Treatment Goals and Monitoring
- For most patients with locoregional and metastatic recurrence, palliative chemotherapy is the standard option 2, 3, 4, 5, 6
When Surgery May Be Considered
- Pelvic surgery is an option only in highly selected cases of locoregional recurrence, not for disseminated disease with lung metastases 2, 3, 4, 5, 6